Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
Journal Article (Clinical Trial, Phase III;Letter)
Full Text
Duke Authors
Cited Authors
- Walter, RB; Michaelis, LC; Othus, M; Uy, GL; Radich, JP; Little, RF; Hita, S; Saini, L; Foran, JM; Gerds, AT; Klepin, HD; Hay, AE; Assouline, S; Lancet, JE; Couban, S; Litzow, MR; Stone, RM; Erba, HP
Published Date
- February 2018
Published In
Volume / Issue
- 93 / 2
Start / End Page
- E49 - E52
PubMed ID
- 29164656
Pubmed Central ID
- 29164656
Electronic International Standard Serial Number (EISSN)
- 1096-8652
Digital Object Identifier (DOI)
- 10.1002/ajh.24980
Language
- eng
Conference Location
- United States